Kelly Howard
Women's Health · Florence, ALNPI 1427208644
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Novo Nordisk at 38.4% of the total. Reporting peaked in 2021 at $743 and has fallen 86.2% since, to $102 in 2025.
Across 110 payments — averaging $18.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$785
- AbbVie$335
- Pfizer$113
- Bausch Health US, LLC$107
- Astellas Pharma US Inc$86
- Agile Therapeutics, Inc.$84
- plus $531 from 17 others
What the payments were for
- Food & beverage$2,041100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 35 | $785 |
| AbbVie | 23 | $335 |
| Pfizer | 6 | $113 |
| Bausch Health US, LLC | 7 | $107 |
| Astellas Pharma US Inc | 5 | $86 |
| Agile Therapeutics, Inc. | 5 | $84 |
| Biohaven Pharmaceuticals, Inc. | 3 | $61 |
| Aspira Women's Health Inc | 1 | $54 |
| Scynexis, Inc. | 3 | $50 |
| Mayne Pharma Commercial LLC | 3 | $47 |
| Bayer | 2 | $42 |
| Urovant Sciences Inc | 2 | $38 |
| Shield Therapeutics Inc | 2 | $37 |
| Lilly USA, LLC | 2 | $28 |
| Organon | 2 | $28 |
| Exeltis, USA Inc. | 2 | $23 |
| Roche Diagnostics Corporation | 1 | $21 |
| Virtus Pharmaceuticals LLC | 1 | $20 |
| Shockwave Medical, Inc | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Smith+Nephew | 1 | $15 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Evofem Biosciences, Inc. | 1 | $14 |
How this compares
$2,041 in reported general payments places this provider in the 80th percentile of 107 women's health providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 39 | $4,763 |
| ProgesteroneProgesterone, Micronized | 61 | $4,683 |
| Estradiol | 66 | $1,361 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 45 | $1,305 |
| DottiEstradiol | 13 | $1,221 |
| Clobetasol Propionate | 11 | $847 |
| ValacyclovirValacyclovir Hcl | 12 | $378 |
| Fluconazole | 28 | $109 |
| Escitalopram Oxalate | 11 | $102 |
| Zolpidem Tartrate | 12 | $98 |
| Lorazepam | 13 | $12 |
Paid to pharmacies, not to this prescriber.
Other women's health in Florence
- Stormie PereaFlorence$2K
- April BrooksFlorence$2K
- Ashton TureaudBirmingham$26K
- Mary MatteiMobile$10K
- Kathryn LyleBirmingham$7K
- Tracy BrownFoley$6K
- Kimberly PeekHuntsville$6K
- Karen HammondHoover$6K
- Jessica MorrisonBirmingham$5K
- Dawna FranklinBirmingham$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.